Want to join the conversation?
$HBI 2Q15 Q&A: Saad of Evercore ISI asked for update on international side. Rich answered by asking not to read anything about repurchases as being part of the mix as a negative about acquisitions. Still focused on acquisitions, doing it and not changing time frames and what company is thinking about acquisitions.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.